ATAD5
ATPase family AAA domain-containing protein 5
Also known as: ATAD5_HUMAN, C17orf41, ELG1, FLJ12735, FRAG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96QE3
- Gene
- ATAD5
- Ensembl
- ENSG00000176208
- Chromosome
- 17
- Canonical length
- 1844 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol
OverviewNCBI Gene
Enables DNA clamp unloader activity. Involved in positive regulation of DNA replication and positive regulation of cell cycle G2/M phase transition. Part of Elg1 RFC-like complex. Biomarker of neurilemmoma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1844 residues, UniProt reviewed canonical sequence.
>Q96QE3|ATAD5
1 MVGVLAMAAA AAPPPVKDCE IEPCKKRKKD DDTSTCKTIT KYLSPLGKTR DRVFAPPKPS
61 NILDYFRKTS PTNEKTQLGK ECKIKSPESV PVDSNKDCTT PLEMFSNVEF KKKRKRVNLS
121 HQLNNIKTEN EAPIEISSDD SKEDYSLNND FVESSTSVLR YKKQVEVLAE NIQDTKSQPN
181 TMTSLQNSKK VNPKQGTTKN DFKKLRKRKC RDVVDLSESL PLAEELNLLK KDGKDTKQME
241 NTTSHANSRD NVTEAAQLND SIITVSYEEF LKSHKENKVE EIPDSTMSIC VPSETVDEIV
301 KSGYISESEN SEISQQVRFK TVTVLAQVHP IPPKKTGKIP RIFLKQKQFE MENSLSDPEN
361 EQTVQKRKSN VVIQEEELEL AVLEAGSSEA VKPKCTLEER QQFMKAFRQP ASDALKNGVK
421 KSSDKQKDLN EKCLYEVGRD DNSKKIMENS GIQMVSKNGN LQLHTDKGSF LKEKNKKLKK
481 KNKKTLDTGA IPGKNREGNT QKKETTFFLK EKQYQNRMSL RQRKTEFFKS STLFNNESLV
541 YEDIANDDLL KVSSLCNNNK LSRKTSIPVK DIKLTQSKAE SEASLLNVST PKSTRRSGRI
601 SSTPTTETIR GIDSDDVQDN SQLKASTQKA ANLSEKHSLY TAELITVPFD SESPIRMKFT
661 RISTPKKSKK KSNKRSEKSE ATDGGFTSQI RKASNTSKNI SKAKQLIEKA KALHISRSKV
721 TEEIAIPLRR SSRHQTLPER KKLSETEDSV IIIDSSPTAL KHPEKNQKKL QCLNDVLGKK
781 LNTSTKNVPG KMKVAPLFLV RKAQKAADPV PSFDESSQDT SEKSQDCDVQ CKAKRDFLMS
841 GLPDLLKRQI AKKAAALDVY NAVSTSFQRV VHVQQKDDGC CLWHLKPPSC PLLTKFKELN
901 TKVIDLSKCG IALGEFSTLN SKLKSGNSAA VFMRTRKEFT EEVRNLLLEE IRWSNPEFSL
961 KKYFPLLLKK QIEHQVLSSE CHSKQELEAD VSHKETKRKL VEAENSKSKR KKPNEYSKNL
1021 EKTNRKSEEL SKRNNSSGIK LDSSKDSGTE DMLWTEKYQP QTASELIGNE LAIKKLHSWL
1081 KDWKRRAELE ERQNLKGKRD EKHEDFSGGI DFKGSSDDEE ESRLCNTVLI TGPTGVGKTA
1141 AVYACAQELG FKIFEVNASS QRSGRQILSQ LKEATQSHQV DKQGVNSQKP CFFNSYYIGK
1201 SPKKISSPKK VVTSPRKVPP PSPKSSGPKR ALPPKTLANY FKVSPKPKNN EEIGMLLENN
1261 KGIKNSFEQK QITQTKSTNA TNSNVKDVGA EEPSRKNATS LILFEEVDVI FDEDAGFLNA
1321 IKTFMATTKR PVILTTSDPT FSLMFDGCFE EIKFSTPSLL NVASYLQMIC LTENFRTDVK
1381 DFVTLLTANT CDIRKSILYL QFWIRSGGGV LEERPLTLYR GNSRNVQLVC SEHGLDNKIY
1441 PKNTKKKRVD LPKCDSGCAE TLFGLKNIFS PSEDLFSFLK HKITMKEEWH KFIQLLTEFQ
1501 MRNVDFLYSN LEFILPLPVD TIPETKNFCG PSVTVDASAA TKSMNCLARK HSEREQPLKK
1561 SQKKKQKKTL VILDDSDLFD TDLDFPDQSI SLSSVSSSSN AEESKTGDEE SKARDKGNNP
1621 ETKKSIPCPP KTTAGKKCSA LVSHCLNSLS EFMDNMSFLD ALLTDVREQN KYGRNDFSWT
1681 NGKVTSGLCD EFSLESNDGW TSQSSGELKA AAEALSFTKC SSAISKALET LNSCKKLGRD
1741 PTNDLTFYVS QKRNNVYFSQ SAANLDNAWK RISVIKSVFS SRSLLYVGNR QASIIEYLPT
1801 LRNICKTEKL KEQGKSKRRF LHYFEGIHLD IPKETVNTLA ADFPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATAD5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 12 nTPM
- thymus: 4.9 nTPM
- lymph node: 3.3 nTPM
- tonsil: 2.7 nTPM
- retina: 2.3 nTPM
- skin: 2.3 nTPM
Single-cell type
- erythrocyte progenitors: 323 nCPM
- monocyte progenitors: 156 nCPM
- epicardial cells: 130 nCPM
- megakaryocyte progenitors: 120 nCPM
- early primary spermatocytes: 105 nCPM
- neutrophil progenitors: 98 nCPM
Immune cell
- neutrophil: 0.6 nTPM
- NK-cell: 0.5 nTPM
- plasmacytoid DC: 0.5 nTPM
- basophil: 0.4 nTPM
- naive B-cell: 0.4 nTPM
- eosinophil: 0.3 nTPM
Brain region
- cerebellum: 8.6 nTPM
- white matter: 4.6 nTPM
- cerebral cortex: 4.5 nTPM
- hypothalamus: 4.1 nTPM
- pons: 4.1 nTPM
- amygdala: 3.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.89
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- isotype switching
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- nuclear DNA replication
- positive regulation of B cell proliferation
- positive regulation of cell cycle G2/M phase transition
- positive regulation of DNA replication
- positive regulation of isotype switching to IgG isotypes
- regulation of mitotic cell cycle phase transition
- signal transduction in response to DNA damage
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATAD5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATAD5 as an antibody target. Whether an autoantibody or antibody against ATAD5 could matter depends on whether native ATAD5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATAD5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATAD5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...